Evidence map›Paper›PMID 29655496›Full record

Trial reportLancet (London, England)2018

Effectiveness of a long-lasting piperonyl butoxide-treated insecticidal net and indoor residual spray interventions, separately and together, against malaria transmitted by pyrethroid-resistant mosquitoes: a cluster, randomised controlled, two-by-two factorial design trial.

Natacha Protopopoff, Jacklin F Mosha, Eliud Lukole, Jacques D Charlwood, Alexandra Wright, Charles D Mwalimu, Alphaxard Manjurano, Franklin W Mosha, William Kisinza, Immo Kleinschmidt and 1 more

4 registry-linked trialsOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Lancet (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 267 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
267citing papers in PubMed, 9 pooled it
48.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02288637 nacompletednot on this map

Evaluation of a Novel Long Lasting Insecticidal Net and Indoor Residual Spray Product, Separately and Together, Against Malaria Transmitted by Pyrethroid Resistant Mosquitoes.

TypeinterventionalSponsorLondon School of Hygiene and Tropical MedicineRan2014 to 2018Enrolled3,840ConditionsMalaria, AnaemiaArmsOlyset Plus LLIN, Conventional Olyset LLIN, IRS
NCT04230161 completednot on this mapstarted 2020, after this paper: background citation

Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Rwanda

TypeobservationalSponsorPATHRan2020 to 2022Enrolled3,502ConditionsMalariaArmsStandard long-lasting insecticidal net, Chlorfenapyr insecticide treated net, Indoor residual spraying
NCT04716387 completednot on this mapstarted 2020, after this paper: background citation

Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Mozambique

TypeobservationalSponsorPATHRan2020 to 2022Enrolled8,726ConditionsMalariaArmsStandard LLIN, Piperonyl butoxide ITN, Pyriproxyfen ITN, Chlorfenapyr ITN
NCT05219565 nacompletednot on this mapstarted 2022, after this paper: background citation

Phase III, Open-label, Community-based, Cluster Randomised Controlled Trial to Evaluate the Efficacy, Cost-effectiveness, and Acceptability of Attractive Targeted Sugar Baits (ATSB) for Malaria Burden Reduction in Western Kenya

TypeinterventionalSponsorLiverpool School of Tropical MedicineRan2022 to 2024Enrolled2,962ConditionsMalariaArmsAttractive Targeted Sugar Bait (ATSB)
3 · Its place in the literature

Who cites it

267 citing papers in PubMed, 9 syntheses or guidelines pooled it, 502 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

207 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Natacha ProtopopoffDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: natacha.protopopoff@lshtm.ac.uk.
Jacklin F MoshaNational Institute for Medical Research, Mwanza Medical Research Centre, Mwanza, Tanzania.
Eliud LukolePan-African Malaria Vector Research Consortium, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Jacques D CharlwoodDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
Alexandra WrightDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
Charles D MwalimuMinistry of Health Community Development Gender Elderly and Children, National Malaria Control Program, Dar es Salaam, Tanzania.
Alphaxard ManjuranoNational Institute for Medical Research, Mwanza Medical Research Centre, Mwanza, Tanzania.
Franklin W MoshaPan-African Malaria Vector Research Consortium, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
William KisinzaNational Institute for Medical Research, Amani Medical Research Centre, Muheza, Tanzania.
Immo KleinschmidtMRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK; School of Pathology, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
Mark RowlandDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
London School of Hygiene & Tropical Medicine · GBNational Institute for Medical Research · TZKilimanjaro Christian Medical Centre · TZMinistry of Health, Community Development, Gender, Elderly and Children · TZ

Funding

Medical Research Council MR/K012126/1Medical Research Council MR/L004437/1Medical Research Council MR/R006040/1Wellcome Trust
6 · The paper itself

Abstract

backgroundProgress in malaria control is under threat by wide-scale insecticide resistance in malaria vectors. Two recent vector control products have been developed: a long-lasting insecticidal net that incorporates a synergist piperonyl butoxide (PBO) and a long-lasting indoor residual spraying formulation of the insecticide pirimiphos-methyl. We evaluated the effectiveness of PBO long-lasting insecticidal nets versus standard long-lasting insecticidal nets as single interventions and in combination with the indoor residual spraying of pirimiphos-methyl.

methodsWe did a four-group cluster randomised controlled trial using a two-by-two factorial design of 48 clusters derived from 40 villages in Muleba (Kagera, Tanzania). We randomly assigned these clusters using restricted randomisation to four groups: standard long-lasting insecticidal nets, PBO long-lasting insecticidal nets, standard long-lasting insecticidal nets plus indoor residual spraying, or PBO long-lasting insecticidal nets plus indoor residual spraying. Both standard and PBO nets were distributed in 2015. Indoor residual spraying was applied only once in 2015. We masked the inhabitants of each cluster to the type of nets received, as well as field staff who took blood samples. Neither the investigators nor the participants were masked to indoor residual spraying. The primary outcome was the prevalence of malaria infection in children aged 6 months to 14 years assessed by cross-sectional surveys at 4, 9, 16, and 21 months after intervention. The endpoint for assessment of indoor residual spraying was 9 months and PBO long-lasting insecticidal nets was 21 months. This trial is registered with ClinicalTrials.gov, number NCT02288637.

findings7184 (68·0%) of 10 560 households were selected for post-intervention survey, and 15 469 (89·0%) of 17 377 eligible children from the four surveys were included in the intention-to-treat analysis. Of the 878 households visited in the two indoor residual spraying groups, 827 (94%) had been sprayed. Reported use of long-lasting insecticidal nets, across all groups, was 15 341 (77·3%) of 19 852 residents after 1 year, decreasing to 12 503 (59·2%) of 21 105 in the second year. Malaria infection prevalence after 9 months was lower in the two groups that received PBO long-lasting insecticidal nets than in the two groups that received standard long-lasting insecticidal nets (531 [29%] of 1852 children vs 767 [42%] of 1809; odds ratio [OR] 0·37, 95% CI 0·21-0·65; p=0·0011). At the same timepoint, malaria prevalence in the two groups that received indoor residual spraying was lower than in groups that did not receive indoor residual spraying (508 [28%] of 1846 children vs 790 [44%] of 1815; OR 0·33, 95% CI 0·19-0·55; p<0·0001) and there was evidence of an interaction between PBO long-lasting insecticidal nets and indoor residual spraying (OR 2·43, 95% CI 1·19-4·97; p=0·0158), indicating redundancy when combined. The PBO long-lasting insecticidal net effect was sustained after 21 months with a lower malaria prevalence than the standard long-lasting insecticidal net (865 [45%] of 1930 children vs 1255 [62%] of 2034; OR 0·40, 0·20-0·81; p=0·0122).

interpretationThe PBO long-lasting insecticidal net and non-pyrethroid indoor residual spraying interventions showed improved control of malaria transmission compared with standard long-lasting insecticidal nets where pyrethroid resistance is prevalent and either intervention could be deployed to good effect. As a result, WHO has since recommended to increase coverage of PBO long-lasting insecticidal nets. Combining indoor residual spraying with pirimiphos-methyl and PBO long-lasting insecticidal nets provided no additional benefit compared with PBO long-lasting insecticidal nets alone or standard long-lasting insecticidal nets plus indoor residual spraying.

fundingUK Department for International Development, Medical Research Council, and Wellcome Trust.

Indexed as

Insecticide ResistanceInsecticide-Treated BednetsAdolescentAnimalsChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantInsecticidesMalariaMaleMosquito VectorsOrganothiophosphorus CompoundsPesticide SynergistsInsecticidesOrganothiophosphorus CompoundsPesticide SynergistsPiperonyl Butoxidepirimiphos methylPyrethrins

Identifiers

PMID29655496
PMCPMC5910376
OpenAlexW2796879453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.